Skip to main content
MADRIGAL PHARMACEUTICALS, INC. logo

MADRIGAL PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · MDGL ISIN · US5588681057 LEI · 549300CHIMT2EUSNJB60 US Manufacturing
Filings indexed 1,022 across all filing types
Latest filing 2023-03-03 Annual Report
Country US United States of America
Listing US MDGL

About MADRIGAL PHARMACEUTICALS, INC.

https://www.madrigalpharma.com/

Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious and progressive liver disease with high unmet medical need. The company's research led to the first U.S. Food and Drug Administration (FDA)-approved treatment for MASH. Madrigal's therapeutic goal is to halt or reverse liver scarring (fibrosis) and resolve the disease before patients experience severe complications, including cirrhosis, liver failure, and the need for transplantation.

Recent filings

Filing Released Lang Actions
10-K/A
Annual Report FY 2022
2023-03-03 English
FORM 4 SUBMISSION
Director's Dealing
2023-03-02 English
10-K
Annual Report FY 2022
2023-02-23 English
8-K Filing
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated February 23, 2023, by Madrigal Pharmaceuticals, Inc. It announces the release of the company's financial results for the fiscal quarter and year ended December 31, 2022, via a press release attached as Exhibit 99.1. The text explicitly states that the press release is furnished as an exhibit and incorporated by reference, and the document itself does not contain detailed financial statements or substantive financial data. The length of the document is 3709 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is an initial announcement of quarterly/year-end financial results, fitting the definition of an Earnings Release (ER).
2023-02-23 English
SC 13G/A
Major Shareholding Notification
2023-02-14 English
Major Shareholding Notification 2023
Major Shareholding Notification
2023-02-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.